IBKS No3 SPAC (KQ:225430) — Market Cap & Net Worth
Market Cap & Net Worth: IBKS No3 SPAC (225430)
IBKS No3 SPAC (KQ:225430) has a market capitalization of $9.77 Million (₩14.42 Billion) as of May 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #26933 globally and #1987 in its home market, demonstrating a -35.46% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IBKS No3 SPAC's stock price ₩517.00 by its total outstanding shares 27887011 (27.89 Million). Analyse 225430 cash flow conversion to see how efficiently the company converts income to cash.
IBKS No3 SPAC Market Cap History: 2020 to 2026
IBKS No3 SPAC's market capitalization history from 2020 to 2026. Data shows change from $55.09 Million to $9.77 Million (-28.21% CAGR).
Index Memberships
IBKS No3 SPAC is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$299.07 Billion | 0.00% | #1098 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$299.07 Billion | 0.00% | #1098 of 1384 |
Weight: IBKS No3 SPAC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
IBKS No3 SPAC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IBKS No3 SPAC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
IBKS No3 SPAC's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $55.09 Million | $22.93 Billion | $470.88 Million | 0.00x | 0.12x |
| 2021 | $42.05 Million | $22.71 Billion | -$219.78 Million | 0.00x | N/A |
| 2022 | $30.05 Million | $15.63 Billion | -$3.92 Billion | 0.00x | N/A |
| 2023 | $18.48 Million | $17.77 Billion | -$1.32 Billion | 0.00x | N/A |
| 2024 | $12.95 Million | $14.47 Billion | -$4.57 Billion | 0.00x | N/A |
| 2025 | $10.17 Million | $15.99 Billion | -$3.97 Billion | 0.00x | N/A |
Competitor Companies of 225430 by Market Capitalization
Companies near IBKS No3 SPAC in the global market cap rankings as of May 4, 2026.
Key companies related to IBKS No3 SPAC by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #140 globally with a market cap of $155.79 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #245 globally with a market cap of $99.82 Billion USD ( CA$137.99 Billion CAD).
- Blackstone Group Inc (NYSE:BX): Ranked #267 globally with a market cap of $94.60 Billion USD.
- KKR & Co LP (NYSE:KKR): Ranked #280 globally with a market cap of $92.43 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #140 | BlackRock Inc | NYSE:BLK | $155.79 Billion | $1061.68 |
| #245 | Brookfield Corporation | TO:BN | $99.82 Billion | CA$61.48 |
| #267 | Blackstone Group Inc | NYSE:BX | $94.60 Billion | $126.35 |
| #280 | KKR & Co LP | NYSE:KKR | $92.43 Billion | $103.68 |
IBKS No3 SPAC Historical Marketcap From 2020 to 2026
Between 2020 and today, IBKS No3 SPAC's market cap moved from $55.09 Million to $ 9.77 Million, with a yearly change of -28.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩9.77 Million | -3.90% |
| 2025 | ₩10.17 Million | -21.46% |
| 2024 | ₩12.95 Million | -29.96% |
| 2023 | ₩18.48 Million | -38.49% |
| 2022 | ₩30.05 Million | -28.54% |
| 2021 | ₩42.05 Million | -23.67% |
| 2020 | ₩55.09 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of IBKS No3 SPAC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.77 Million USD |
| MoneyControl | $9.77 Million USD |
| MarketWatch | $9.77 Million USD |
| marketcap.company | $9.77 Million USD |
| Reuters | $9.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IBKS No3 SPAC
KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, an… Read more